FilingReader Intelligence
Tibet Rhodiola proposes CNY 8.81 dividend, dissolves supervisory board
August 15, 2025 at 09:09 AM UTC•By FilingReader AI
Tibet Rhodiola Pharmaceutical proposed a cash dividend of CNY 8.81 per 10 shares and approved dissolving its supervisory board, transferring functions to an audit committee.
The company reported a 2.23% increase in operating revenue in its semi-annual results.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement by Tibet NordeKang Pharmaceutical Company Limited regarding the abolition of the board of supervisors and the revision of the articles of association and certain internal regulationsAugust 15, 2025 at 08:00 AM UTC
Tibet Pharmaceutical 2025 semi-annual report summaryAugust 15, 2025 at 08:00 AM UTC
Announcement of resolutions from the tenth meeting of the eighth board of directors of Tibet Nordic Pharma Co., Ltd.August 15, 2025 at 08:00 AM UTC
SSE:600211•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Tibet Rhodiola Pharmaceutical Holding publishes news
Free account required • Unsubscribe anytime